Cargando…

Efficacy and safety of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy: A systematic review and meta-analysis

INTRODUCTION: Programmed cell death-1/programmed cell death ligand-1 (PD-1/PDL-1) inhibitors are the newest class of approved drugs for advanced urothelial cancer (AdUC). This review aims to collate the evidence for their efficacy and safety in various treatment settings. METHODS: Extensive search o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pattanaik, Smita, Dey, Sumit, Jaiswal, Nishant, Rohilla, Rachna, Singh, Shrawan Kumar, Mandal, Arup Kumar, Mavuduru, Ravimohan Suryanarayan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458809/ https://www.ncbi.nlm.nih.gov/pubmed/31000914 http://dx.doi.org/10.4103/iju.IJU_357_18

Ejemplares similares

Efficacy of tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms: A randomized double blind placebo controlled cross-over study
por: Pattanaik, Smita, et al.
Publicado: (2019)

Endothelial Dysfunction in Patients With Erectile Dysfunction: A Double-Blind, Randomized-Control Trial Using Tadalafil
por: Pattanaik, Smita, et al.
Publicado: (2019)

Somatic Mutations Profile of a Young Patient With Metastatic Urothelial Carcinoma Reveals Mutations in Genes Involved in Ion Channels
por: Sharma, Jyoti, et al.
Publicado: (2019)

Utility of restage transurethral resection of bladder tumor
por: Manoharan, Vignesh, et al.
Publicado: (2018)

Protocol-based perioperative antimicrobial prophylaxis in urologic surgeries: Feasibility and lessons learned
por: Sharma, Aditya Prakash, et al.
Publicado: (2019)

Robot-assisted surgery in India: A SWOT analysis
por: Bora, Girdhar Singh, et al.
Publicado: (2020)

WhatsApp use in urological practice: Yin and Yang!
por: Sharma, Aditya Prakash, et al.
Publicado: (2019)

Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019)

Are urine flow-volume nomograms developed on Caucasian men optimally applicable for Indian men? Need for appraisal of flow-volume relations in local population
por: Agarwal, Mayank M., et al.
Publicado: (2010)

Plateau pattern of detrusor contraction: A surrogate indicator of presence of external sphincter dysfunction during micturitional phase of urodynamic study
por: Agarwal, Mayank Mohan, et al.
Publicado: (2016)

Voiding dysfunction after repair of giant trigonal vesicovaginal or urethrovesicovaginal fistulae: A need for long-term follow-up
por: Agarwal, Mayank Mohan, et al.
Publicado: (2012)

Instrument malfunction during robotic surgery: A case report
por: Singh, Shivanshu, et al.
Publicado: (2016)

Robot-assisted partial nephrectomy for moderate to highly complex renal masses. A systematic review and meta-analysis
por: Sharma, Gopal, et al.
Publicado: (2022)

Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation
por: Lee, Kyu Sang, et al.
Publicado: (2021)

Predicting trifecta outcomes after robot-assisted nephron-sparing surgery: Beyond the nephrometry score
por: Sharma, Aditya P., et al.
Publicado: (2018)

Health-Related Quality-of-Life Outcomes with Actinium-225-Prostate-Specific Membrane Antigen-617 Therapy in Patients with Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer
por: Satapathy, Swayamjeet, et al.
Publicado: (2020)

Perioperative outcomes of minimally invasive versus open radical cystectomy: A single-center experience
por: Panwar, Pankaj, et al.
Publicado: (2018)

STAMPEDEing metastatic prostate cancer: CHAARTing the LATITUDEs
por: Sharma, Aditya Prakash, et al.
Publicado: (2018)

Safety and efficacy of active surveillance in patients with localized prostate cancer
por: Mavuduru, Ravimohan, et al.
Publicado: (2008)

(177)Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial
por: Satapathy, Swayamjeet, et al.
Publicado: (2021)

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
por: Rosenberg, Jonathan E., et al.
Publicado: (2019)

Isolated Bilateral Renal Mucormycosis Masquerading as Renal Abscess in an Immunocompetent Individual: A Lesson Learnt
por: Paonam, Somorendro, et al.
Publicado: (2014)

Quantifying prognosis severity of COVID-19 patients from deep learning based analysis of CT chest images
por: Rana, Ashish, et al.
Publicado: (2022)

Fertility preservation in men: Perspective
por: Sharma, Aditya Prakash, et al.
Publicado: (2018)

Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
por: Banerjee, Debasree, et al.
Publicado: (2018)

Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
por: Jaafar, Jaafar, et al.
Publicado: (2018)

Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis
por: Liao, Pei-Fei, et al.
Publicado: (2023)

Safety and Activity of Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors for Platinum-Resistant Urothelial Cancer: A Meta-Analysis of Published Clinical Trials
por: Li, Zaishang, et al.
Publicado: (2021)

Expression patterns of programmed death-1 and programmed death-1 ligand-1 on T cells in gastric cancer
por: Kim, Ji-Hyun, et al.
Publicado: (2019)

Initial experience of robotic nephron sparing surgery in cases of high renal nephrometry scores
por: Bora, Girdhar S., et al.
Publicado: (2017)

Prominent swelling on erection: Perineal angiomyxoma as a rare entity
por: Tyagi, Shantanu, et al.
Publicado: (2019)

Hairy cell leukemia expresses programmed death-1
por: Kumar, Priyadarshini, et al.
Publicado: (2020)

Management of the stricture of fossa navicularis and pendulous urethral strictures
por: Singh, Shrawan K., et al.
Publicado: (2011)

Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
por: Zhang, Yan, et al.
Publicado: (2011)

Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis
por: Liu, Qiang, et al.
Publicado: (2017)

Preventive fluid and dietary therapy for urolithiasis: An appraisal of strength, controversies and lacunae of current literature
por: Agarwal, Mayank Mohan, et al.
Publicado: (2011)

Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity
por: Niedźwiedzka-Rystwej, Paulina, et al.
Publicado: (2022)

Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
por: Chang, Katherine, et al.
Publicado: (2014)

Programmed death ligand‐1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder
por: Wang, Bo, et al.
Publicado: (2018)

Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma
por: Zajac, Magdalena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g9cus62mfltb7g5ovv4kf851h6